atai shareholders approve all proposals including one-tier board; Anne Johnson appointed but will not serve

ATAI Life Sciences N.V.

Adopted 2024 statutory accounts (124M for, 670K against, 12.7M abstain).
Appointed Deloitte as auditor for FY2025 (131M for, 662K against).
Approved one-tier board governance model, removing German tax residency limits, and eliminating supermajority for charter amendments.
John Hoffman appointed as non-executive director; Srinivas Rao as executive director; Anne Johnson appointed as managing director but filing states she will not serve on the board.
Authorized management to issue shares (111M for) and acquire shares (113M for); compensation policy for unitary board approved.

item 5.07

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.